Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · July 18, 2023

Patient-Reported Outcomes Associated With Sarecycline Treatment in Patients With Acne Vulgaris

Journal of the American Academy of Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies
J Am Acad Dermatol 2023 Jun 13;[EPub Ahead of Print], JC Harper, A Armstrong, RG Fried, EA Rieder, AF Alexis, RJ Salem, I Kasujee, A Grada

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading